Allows for rapid titration to the desired depth of analgesia as required by varying levels of intraoperative stress1
Facilitates recovery from inpatient and outpatient surgery1,2
Added characteristics of ULTIVA
Well-established hemodynamic profile in inpatient and outpatient procedures1,2
- Can be used in patients with renal or hepatic impairment1
Thyroidectomy case study
5'3", 52.2 kg (115 lb)
BMI 20.4 kg/m2
- Mild hepatic impairment (Child-Pugh grade A)
- Persistent depressive disorder (diagnosed 6 years ago)
Prior history of alcoholism, 5 years abstinent
No known drug allergies
No family history of adverse reactions to anesthetic agents
The concomitant use of Remi with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome. Carefully observe the patient, particularly during treatment initiation and dose adjustment. Discontinue Remi if serotonin syndrome is suspected1
This case study is for illustrative and educational purposes only. The dosing regimen is specific to this case study and other regimens may vary depending on patient and procedure. Any use of this product is subject to the judgment of the practitioner in each case. Please consult the full Prescribing Information in the use of this product.
- ULTIVA [package insert]. Rockford, IL: Mylan Institutional LLC; 2016.
- Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth. 2001;13(6):407-416. Sponsored by Glaxo Wellcome Inc.